Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) Equity-to-Asset : 0.78 (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Vaidyane Ayurved Laboratories Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Vaidyane Ayurved Laboratories's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₹556.0 Mil. Vaidyane Ayurved Laboratories's Total Assets for the quarter that ended in Mar. 2024 was ₹708.9 Mil. Therefore, Vaidyane Ayurved Laboratories's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.78.

The historical rank and industry rank for Vaidyane Ayurved Laboratories's Equity-to-Asset or its related term are showing as below:

NSE:MADHAVBAUG' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.28 Med: 0.54 Max: 0.78
Current: 0.78

During the past 6 years, the highest Equity to Asset Ratio of Vaidyane Ayurved Laboratories was 0.78. The lowest was 0.28. And the median was 0.54.

NSE:MADHAVBAUG's Equity-to-Asset is ranked better than
78.07% of 1026 companies
in the Drug Manufacturers industry
Industry Median: 0.605 vs NSE:MADHAVBAUG: 0.78

Vaidyane Ayurved Laboratories Equity-to-Asset Historical Data

The historical data trend for Vaidyane Ayurved Laboratories's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vaidyane Ayurved Laboratories Equity-to-Asset Chart

Vaidyane Ayurved Laboratories Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Equity-to-Asset

Get a 7-Day Free Trial

0.28

0.38

0.69

0.74

0.78

Vaidyane Ayurved Laboratories Semi-Annual Data
	Mar19	Mar20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
Equity-to-Asset	Get a 7-Day Free Trial				0.69	-	0.74	0.80	0.78

Competitive Comparison of Vaidyane Ayurved Laboratories's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Vaidyane Ayurved Laboratories's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vaidyane Ayurved Laboratories's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vaidyane Ayurved Laboratories's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Vaidyane Ayurved Laboratories's Equity-to-Asset falls into.

Save Embed

;

Save Embed

;

Vaidyane Ayurved Laboratories Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Vaidyane Ayurved Laboratories's Equity to Asset Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Equity to Asset (A: Mar. 2024 )	=	Total Stockholders Equity	/	Total Assets
	=	556.015	/	708.913
	=	0.78

Vaidyane Ayurved Laboratories's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )	=	Total Stockholders Equity	/	Total Assets
	=	556.015	/	708.913
	=	0.78

Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Vaidyane Ayurved Laboratories Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Vaidyane Ayurved Laboratories's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Vaidyane Ayurved Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vaidya Sane Ayurved Laboratories Ltd (NSE:MADHAVBAUG) » Definitions » Equity-to-Asset

Traded in Other Exchanges

N/A

Address

201B, Bhoomi Velocity, Above ICICI Bank, Road No. 23, Wagle Estate, Thane (West), Thane, MH, IND, 400604

Website

https://www.madhavbaug.org

Vaidya Sane Ayurved Laboratories Ltd is a medical service institution engaged in the treatment of chronic ailments like cardiac disease, diabetes, hypertension, and obesity by combining modern technology with traditional Ayurveda practices. It uses non-invasive, multidisciplinary, and therapies for treating chronic ailments. The company mainly offers treatment for health disease reversal, diabetes reversal, BP management, obesity management and knee pain relief. The company's business is divided into three segments i.e. Hospital Activity, Sale of Product and Common. It derives maximum revenue from Sale of Products.

Vaidyane Ayurved Laboratories Headlines

No Headlines